CLINICAL_TRIALS
trial_result
· 2019-09-04
Clinical Trial Update: Daprodustat Hepatic Impairment Study [Phase 1]
Summary
Phase 1 hepatic impairment study of daprodustat completed; results posted in 2019 for anaemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Anaemia | Phase 1 | Status: COMPLETED | Results posted: 2019-09-04